OMEPRAZOLE VERSUS RANITIDINE IN EROSIVE OESOPHAGITIS

The Lancet

Volumn 330, Issue 8559, 1987, Pages 621-622

  Zeitoun, P ^a   Desjars De Keranroue N ^b   Isal, J P ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b Laboratoires ASTRA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; RANITIDINE;

ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LETTER; MALE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS;

CLINICAL TRIALS; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; ESOPHAGITIS, PEPTIC; FEMALE; HUMAN; MALE; MIDDLE AGE; OMEPRAZOLE; RANDOM ALLOCATION; RANITIDINE;

EID: 0023651907     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)93005-4     Document Type: Letter

References (2)

1. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis
2. Omeprazole (40 mg) is superior to ranitidine in the short term treatment of ulcerative reflux esophagitis